
ESSA Pharma Inc
NASDAQ:EPIX

ROA
Return on Assets
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
ROA Across Competitors
Country | Company | Market Cap | ROA | ||
---|---|---|---|---|---|
CA |
![]() |
ESSA Pharma Inc
NASDAQ:EPIX
|
75.9m USD |
-23%
|
|
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD |
-391%
|
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
339.9B USD |
3%
|
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
158.2B USD |
7%
|
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
137.9B USD |
11%
|
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.9B USD |
-4%
|
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
-67%
|
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
116.6B AUD |
7%
|
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
56.6B USD |
13%
|
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
-21%
|
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.3B USD |
-7%
|
ESSA Pharma Inc
Glance View
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 30 full-time employees. The firm is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The firm is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

See Also
ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.
Based on ESSA Pharma Inc's most recent financial statements, the company has ROA of -22.5%.